World-first stem cell therapy trial shows promise for treating spina bifida in the womb

nature.com

A world-first stem-cell therapy trial for spina bifida in the womb has shown promising safety results. Six pregnant women received placenta-derived stem cells applied to fetal spinal cords during gestation. The newborns showed no immediate complications, and a key brain complication reversed. This experimental treatment aims to improve outcomes for spina bifida, a condition affecting fetal spinal cord development, offering potential benefits beyond current surgical interventions.


With a significance score of 6.5, this news ranks in the top 0.1% of today's 29310 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: